[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351527-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351527-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","helicobacter-pylori-induced-inflammatory-cancer-transformation-microenvironment-drives-gastric-carcinogenesis","Helicobacter pylori-Induced Inflammatory Cancer Transformation - Microenvironment Drives Gastric Carcinogenesis","","Helicobacter pylori infection induces immunomodulatory cancer-associated fibroblasts that drive epithelial malignant transformation and immunosuppression, sustaining a persistent inflammatory-cancer-transformation microenvironment after eradication. A single-cell atlas of gastric antral mucosa across disease stages reveals distinct post-eradication epithelial trajectories linked to fibrosis and immune remodeling. iCAF subtypes enriched in infected tissues persist in post-eradication chronic atrophic gastritis, reprogramming extracellular matrix, inducing senescence-associated secretory phenotype, and promoting stemness.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/helicobacter-pylori-induced-inflammatory-cancer-transformation-microenvironment-drives-gastric-carcinogenesis/351527/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/helicobacter-pylori-induced-inflammatory-cancer-transformation-microenvironment-drives-gastric-carcinogenesis/351527.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn Holloway","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does Helicobacter pylori infection cause in relation to gastric cancer progression?","Question",{"text":63,"@type":64},"Helicobacter pylori infection induces immunomodulatory cancer-associated fibroblasts that drive epithelial malignant transformation and immunosuppression, shaping an inflammatory cancer transformation microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why does Helicobacter pylori eradication not fully prevent cancer progression in advanced atrophic gastritis?",{"text":68,"@type":64},"Even after eradication, a persistent inflammatory-cancer-transformation microenvironment continues to drive gastric carcinogenesis, indicating residual oncogenic risk.",{"name":70,"@type":61,"acceptedAnswer":71},"What key cellular changes were observed after eradication?",{"text":72,"@type":64},"After eradication, epithelial cells follow distinct trajectories; the pathological improvement group shows increased MUC5AC expression, while the non-improvement group displays a malignant trajectory associated with persistent immunomodulatory CAF states.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351527,1790147450,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","ORIGINAL RESEARCH  \nHelicobacter pylori-Induced Inflammatory Cancer Transformation   Microenvironment Drives Gastric Carcinogenesis  \nYufei Fu,2 ,* Jiajing Tong,3 ,4 ,* Manxuan Zhu,2 ,* Liuyi Xu,1 Fengming Huang,2 Yixin Zhang,2 Xinyue Wang,2 Zhejiong Wang,2 Jingcheng Zhang, 1 Jinjing Lv,2 Tao Jiang,1 Bin Lv,2 ,5 and Guangji Zhang1  \n1Zhejiang Key Laboratory of Blood-Stasis-Toxin Syndrome, Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China; 2Key Laboratory of Digestive Pathophysiology of Zhejiang Province, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China; 3Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang, China; 4Department of Gastroenterology, School of Pharmacy, Zhejiang University of Technology, Hangzhou, China; and 5Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, China  \nSUMMARY  \nHerein, we demonstrate that Helicobacter pylori infection induces immunomodulatory cancer-associated fibroblasts that drive epithelial malignant transformation and immunosuppression. Our findings also indicate promising therapeutic targets for preventing cancer progression, even after Helicobacter pylori eradication.  \nBACKGROUND & AIMS: Helicobacter pylori (H pylori) eradication significantly reduces gastric cancer risk but offers limited benefit for patients with advanced atrophic gastritis. After eradication, a persistent inflammatory-cancer-transformation microenvironment (ICTM) drives gastric carcinogenesis, warranting further investigation.  \nMETHODS: We constructed a single-cell atlas of 22 gastric antral mucosae across disease stages, including normal controls, H pylori-infected non-atrophic gastritis, H pylori-infected chronic atrophic gastritis, and post-eradication chronic atrophic gastritis (stratified by pathological improvement) . Key findings were validated via multiplex immunofluorescence and primary cancer-associated fibroblast (CAF) experiments.  \nWHAT YOU NEED TO KNOW  \nBackground: Helicobacter pylori eradication reduces gastric cancer risk but does not prevent disease progression in advanced atrophic gastritis, where a self-sustaining oncogenic microenvironment persists. The contribution offibroblast heterogeneity to this process remains unclear.  \nImpact: Post-eradication, epithelial cells in advanced precancerous mucosa follow a malignant trajectory driven by immunomodulatory cancer-associated fibroblasts (iCAFs) . These cells reprogram the extracellular matrix and sustain an immunosuppressive niche linked to persistent pathology.  \nFuture Directions: The persistence of iCAFs post-eradication indicates residual cancer risk. Targeting specific iCAFs emerges as a promising strategy to halt malignant transformation in advanced atrophic gastritis.  \nRESULTS: H pylori infection profoundly alters the ICTM within immune and stromal cells during and after eradication. Following eradication, epithelial cells exhibit distinct trajectories after eradication, with the pathological improvement group showing increased MUC5AC expression and the non-improvement group  \n2 Fu et al Cellular and Molecular Gastroenterology and Hepatology Vol. 20, Iss. 7  \ndisplaying a malignant trajectory. Immunomodulatory CAFs (iCAFs) critically promote epithelial malignancy and immunosuppression. CCN2+ iCAF1 and C3+ iCAF3 are enriched in infected tissues and persist in post-eradication patients with CAG. H pylori infection reprograms iCAFs, leading to extracellular matrix reorganization and senescence with senescence-associated secretory phenotype. This reprogramming promotes epithelial malignant transformation and stemness. Infection-driven reprogramming of the iCAF-epithelial niche is accompanied by an immunosuppressive state after eradication.  \nCONCLUSIONS: H pylori infe","cbCain07ofpEJrDW","https://ap.wps.com/l/cbCain07ofpEJrDW","pdf",45908901,29,"English","# Summary\n## Background & Aims\n## Methods\n## What You Need to Know\n## Results\n## Conclusions","[{\"question\":\"What does Helicobacter pylori infection cause in relation to gastric cancer progression?\",\"answer\":\"Helicobacter pylori infection induces immunomodulatory cancer-associated fibroblasts that drive epithelial malignant transformation and immunosuppression, shaping an inflammatory cancer transformation microenvironment.\"},{\"question\":\"Why does Helicobacter pylori eradication not fully prevent cancer progression in advanced atrophic gastritis?\",\"answer\":\"Even after eradication, a persistent inflammatory-cancer-transformation microenvironment continues to drive gastric carcinogenesis, indicating residual oncogenic risk.\"},{\"question\":\"What key cellular changes were observed after eradication?\",\"answer\":\"After eradication, epithelial cells follow distinct trajectories; the pathological improvement group shows increased MUC5AC expression, while the non-improvement group displays a malignant trajectory associated with persistent immunomodulatory CAF states.\"}]","Helicobacter pylori-Induced Inflammatory Cancer Transformation - Microenvironment Drives Gastric Carcinogenesis | PDF",1790094598,73,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47cf770e19ec05846e651fa5f2d28725.webp",983,1296,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28ac19b4865afbcd3a4a3298ed92d9c0.webp",982,1294,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/419d1277fc9fc6da0ca7c26b67337527.webp",981,1293,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47fcfa478304cc5f5c5d49679778d74e.webp",980,1292]